DeepSeek AI Chinese Startup Claims CostEffective AI Model Training Without Advanced Chips US April Payrolls Surge Beyond Expectations Yet Economic Undercurrents Raise Concerns Mercury Fintech Startup Valuation Reaches 52 Billion Following 200 Million Funding Round Tulsi Gabbard Resigns as Director of National Intelligence Citing Husbands Cancer Battle Mercury Fintech Valuation Hits 52 Billion After Funding Surge Up 49 in 14 Months Synopsys Appoints Elliott Management Partner Jesse Cohn to Board of Directors OM Q1 2026 Earnings EPS Misses Estimates as Outset Medical Posts WiderThanExpected Loss Stock Edges Up enGene Holdings Q1 2026 Earnings EPS Beat and Positive Market Response Amid PreRevenue Progress BorgWarner BWA Q1 2026 Earnings EPS Surprises to the Upside Shares Gain Nearly 4 CUZ Q1 2026 Earnings EPS Beats Estimates by 155 Shares Edge Higher DTG Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment Standex International Corporation SXI Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gains Savers Value Village SVV Edges Higher as Value Retail Navigates Consumer Caution Lexicon Pharmaceuticals LXRX Slides 314 as Shares Test NearTerm Support Levels Lineage Cell Therapeutics LCTX Holds Near Support as Biotech Sector Headwinds Persist KTech Solutions KMRK Holds Steady at 202 Amid Key Technical Levels AptarGroup Holds Steady Near Support as LowVolume Drift Points to Indecision Generative AI and ChatGPT Emerging Tools for Coping With Situational Depression TIPT Q2 2025 Earnings EPS of 058 Reported Amid Modest Stock Decline CNFinance Holdings CNF Advances Can Momentum Sustain Above Key Levels AirJoule Technologies Warrant AIRJW Rises 2057 as Traders Test Key Resistance Northeast Bank NBN Holds Near Resistance After Modest Decline CHMI Shares Slide Toward Key Support as Mortgage REIT Faces Headwinds OTGAW Warrants Hold Steady at 036 Amid Quiet Trading Support and Resistance Levels in Focus ADMA Biologics Slides as Shares Test Key Support Levels BNY Mellon Strategic Municipals Inc LEO Edges Higher in Modest Uptrend Agenus AGEN Rallies 22 Biotech Momentum Faces Key Resistance at 356